Acumen Pharmaceuticals Stock Statistic Functions Linear Regression Intercept

ABOS Stock

USD 3.30 -0.07 -2.08%

Use the statistic functions workspace to apply Linear Regression Intercept function and other studies to Acumen Pharmaceuticals. The analysis highlights statistical functions describing dispersion and variability and frames technical signals with volatility and risk context.Enter Time Period to execute this module.

Symbol

The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Linear Regression Intercept is the expected mean value of Acumen Pharmaceuticals price seriese where values of its benchmark or peer price series are zero.

Acumen Pharmaceuticals Technical Analysis Modules

Most technical analysis of Acumen Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Acumen from various momentum indicators to cycle indicators. When you analyze Acumen charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

	Cycle Indicators
	Math Operators
	Math Transform
	Momentum Indicators
	Overlap Studies
	Pattern Recognition
	Price Transform
	Statistic Functions
	Volatility Indicators
	Volume Indicators

Stock Overview, Methodology & Data Sources

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimers disease. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia. Acumen Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 14 people. This stock section frames Acumen Pharmaceuticals within its peer set and highlights how fundamentals align with price behavior. Current metrics include P/B of 2.19. Acumen Pharmaceuticals has a market cap of 204.13 M, ROE of -85.93%.

Methodology

Unless otherwise specified, financial data for Acumen Pharmaceuticals is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Acumen (USA Stocks:ABOS) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Information presented is compiled from public filings and market reference sources and official institutions such as U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Updates can be delayed depending on reporting conventions. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Acumen Pharmaceuticals is covered by 6 analysts. 3 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Morgan Stanley, Goldman Sachs, Citigroup, Raymond James, Deutsche Bank, Evercore ISI, Guggenheim Securities, UBS Investment Research, among others. Updates may occur throughout the day.

This content is curated and reviewed by:

Michael Smolkin - Member of Macroaxis Board of Directors

Become your own money manager

Tracking Acumen Pharmaceuticals inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.

Did you try this?

Run Global Markets Map Now

Global Markets Map

Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes

All Next

Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.

	Momentum Invested few shares	Go
	Warren Buffett Holdings Invested over 20 shares	Go
	Macroaxis Index Invested over 60 shares	Go
	Adviser Favorites Invested few shares	Go
	Blockchain Invested few shares	Go
	Advertising Invested few shares	Go
	Investor Favorites Invested few shares	Go
	Video Games Invested few shares	Go
	Impulse Invested over 200 shares	Go

Additional Tools for Acumen Stock Analysis

	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators
	Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments
	Analyst Advice Analyst recommendations and target price estimates broken down by several categories
	Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	Global Correlations Find global opportunities by holding instruments from different markets

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC